TPG GP A’s Amneal Pharmaceuticals AMRX Stock Holding History

TPG GP A’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$213M	Hold	12,328,767	–	–	4.27%	7
2026 Q1	$153M	Hold	12,328,767	–	–	4.17%	6
2025 Q4	$155M	Hold	12,328,767	–	–	5.78%	5
2025 Q3	$123M	Hold	12,328,767	–	–	6.72%	4
2025 Q2	$99.7M	Hold	12,328,767	–	–	5.32%	4
2025 Q1	$103M	Hold	12,328,767	–	–	2.04%	11
2024 Q4	$97.6M	Hold	12,328,767	–	–	1.58%	14
2024 Q3	$103M	Hold	12,328,767	–	–	1.75%	14
2024 Q2	$78.3M	Hold	12,328,767	–	–	1.22%	18
2024 Q1	$74.7M	Hold	12,328,767	–	–	1.43%	22
2023 Q4	$74.8M	Hold	12,328,767	–	–	1.21%	22
2023 Q3	$52M	Hold	12,328,767	–	–	0.9%	24
2023 Q2	$38.2M	Hold	12,328,767	–	–	0.56%	29
2023 Q1	$17.1M	Hold	12,328,767	–	–	0.28%	33
2022 Q4	$24.5M	Sell	12,328,767 -3,884,600	-24%	-$8.71M	0.48%	31
2022 Q3	$32.8M	Hold	16,213,367	–	–	0.54%	29
2022 Q2	$51.6M	Hold	16,213,367	–	–	0.8%	26
2022 Q1	$67.6M	Hold	16,213,367	–	–	0.84%	27
2021 Q4	$77.7M	Buy	+16,213,367	New	+$80.8M	0.78%	28

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

TPG GP A's AMRX Position: Q2 2026 in Review

TPG GP A held its Amneal Pharmaceuticals (AMRX) position steady in Q2 2026 at 12,328,767 shares worth $213M. The position accounts for 4.27% of the portfolio, ranked #7.

TPG GP A first reported a position in AMRX in Q4 2021 and has held it in 19 quarters since. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

TPG GP A held 12,328,767 shares of Amneal Pharmaceuticals worth $213M as of Q2 2026.
TPG GP A left its Amneal Pharmaceuticals share count unchanged in Q2 2026.
Amneal Pharmaceuticals made up 4.27% of TPG GP A's portfolio in Q2 2026, its #7 holding.
TPG GP A first reported a position in Amneal Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on TPG GP A's 13F filing for Q2 2026, filed 14 Aug 2026.